Method for adjuvanting lipopolysaccharide (LPS) of gram-negative bacteria
AssigneeSanofi Pasteur Limited
InventorsJean Haensler, Bruno Guy
Life of this patent
Estimating the term…
Loading patent…
AssigneeSanofi Pasteur Limited
InventorsJean Haensler, Bruno Guy
Estimating the term…
The subject of the invention is a method for adjuvanting LPS of a Gram-negative bacterium, according to which LPS or LPS liposomes (LPS formulated in liposomes) is (are) mixed with the lipidated human-transferrin receptor subunit B (TbpB protein) of Neisseria meningitidis or a lipidated fragment thereof; or (ii) LPS and the lipidated TbpB of N. meningitidis or a lipidated fragment thereof are formulated together in liposomes; or (iii) LPS is conjugated with the lipidated TbpB of N. meningitidis or a lipidated fragment thereof; in order to obtain a preparation which does not contain OMVs and which is capable of inducing, after administration to a mammal, an anti-LPS immune response which is improved by comparison with the anti-LPS immune response observed after administration of the corresponding preparation in which the lipidated TbpB of N. meningitidis or a lipidated fragment thereof is omitted; as well as vaccine compositions thereof. The LPS may, for example, be the LOS of a non-enteric Gram-negative bacterium such as N. meningitidis.
A method of making a preparation comprising the lipopolysaccharide (LPS) of a Gram-negative bacterium, the method comprising:
Dependencies are inferred from the claim text.